Knoll Capital Management’s VolitionRx Ltd VNRX Stock Holding History

Knoll Capital Management’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-16,071	Closed	-$916K	–	17
2018 Q3	$916K	Sell	16,071 -1,506	-9%	-$61.9K	0.77%	12
2018 Q2	$703K	Hold	17,577	–	–	0.6%	14
2018 Q1	$844K	Hold	17,577	–	–	0.87%	10
2017 Q4	$1.03M	Sell	17,577 -5,500	-24%	-$322K	0.91%	9
2017 Q3	$1.24M	Hold	23,077	–	–	1.06%	9
2017 Q2	$1.62M	Hold	23,077	–	–	2.15%	6
2017 Q1	$1.85M	Hold	23,077	–	–	2.8%	7
2016 Q4	$2.09M	Hold	23,077	–	–	3.67%	8
2016 Q3	$2.58M	Hold	23,077	–	–	4.52%	8
2016 Q2	$1.45M	Hold	23,077	–	–	0.47%	10
2016 Q1	$1.64M	Buy	+23,077	New	+$1.73M	0.67%	10

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LCM

Leisure Capital Management Costa Mesa, California $320M AUM 39.11% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Knoll Capital Management's VNRX Position: Q4 2018 in Review

Knoll Capital Management sold out of VolitionRx Ltd (VNRX) in Q4 2018, closing a stake of 16,071 shares — an estimated $916K sold.

Knoll Capital Management first reported a position in VNRX in Q1 2016 and held it in 11 quarters. The position peaked at $2.58M in Q3 2016. 25 funds tracked by Wall St. Rank hold VNRX as of Q4 2018.

Knoll Capital Management reported no remaining VolitionRx Ltd position as of Q4 2018 after selling out during the quarter.
Knoll Capital Management sold 16,071 VolitionRx Ltd shares in Q4 2018, an estimated $916K.
Knoll Capital Management first reported a position in VolitionRx Ltd in Q1 2016 and held it in 11 quarters.
Knoll Capital Management's VolitionRx Ltd position peaked at $2.58M in Q3 2016.
25 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2018.

Based on Knoll Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.